Inventor
SKERRA ARNE
DE45 patents
⚠️ This page may combine multiple inventors who share the name “SKERRA ARNE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV MUENCHEN TECH
11 patentsUS9260494B2Feb 16, 2016
Biological active proteins having increased in vivo and/or in vitro stability
UNIV MUENCHEN TECH12 citations80
US9040020B2May 26, 2015
Muteins of hNGAL and related proteins with affinity for a given target
UNIV MUENCHEN TECH4 citations71
US10844094B2Nov 24, 2020
Biosynthetic proline/alanine random coil polypeptides and their uses
UNIV MUENCHEN TECH1 citations70
US10081657B2Sep 25, 2018
Biosynthetic proline/alanine random coil polypeptides and their uses
UNIV MUENCHEN TECH3 citations70
US10406247B2Sep 10, 2019
PSMA-specific binding proteins
UNIV MUENCHEN TECH3 citations64
US9758554B2Sep 12, 2017
Muteins of α1m lipocalin and method of production therefor
UNIV MUENCHEN TECH2 citations64
US11464877B2Oct 11, 2022
PSMA-specific binding proteins
UNIV MUENCHEN TECH0 citations53
US9630998B2Apr 25, 2017
Recombinant bacterial lipocalin Blc and uses thereof
UNIV MUENCHEN TECH0 citations44
US10738092B2Aug 11, 2020
Muteins of a1m lipocalin and method of production therefor
UNIV MUENCHEN TECH0 citations43
US12173038B2Dec 24, 2024
High affinity anticalins directed against human CD98hc
UNIV MUENCHEN TECH0 citations39
US9637471B2May 2, 2017
Hydroxyindalpine derivatives and their medical use
UNIV MUENCHEN TECH0 citations38
SKERRA ARNE
8 patentsUS8536307B2Sep 17, 2013
Anticalins
SKERRA ARNE25 citations91
US9549968B2Jan 24, 2017
Muteins of human lipocalin 2 (LcnC,hNGAL) with affinity for a given target
SKERRA ARNE21 citations90
US9221882B2Dec 29, 2015
Biosynthetic proline/alanine random coil polypeptides and their uses
SKERRA ARNE15 citations89
US8563521B2Oct 22, 2013
Biological active proteins having increased in vivo and/or in vitro stability
SKERRA ARNE32 citations89
US8158753B2Apr 17, 2012
Anticalins
SKERRA ARNE11 citations83
US8420051B2Apr 16, 2013
Muteins of hNGAL and related proteins with affinity for a given target
SKERRA ARNE5 citations82
US8598317B2Dec 3, 2013
Muteins of tear lipocalin with affinity for the T-cell coreceptor CD4
SKERRA ARNE3 citations54
US8987415B2Mar 24, 2015
Recombinant bacterial lipocalin blc and uses thereof
SKERRA ARNE0 citations44
PIERIS AG
7 patentsUS7250297B1Jul 31, 2007
Anticalins
PIERIS AG320 citations98
US7585940B2Sep 8, 2009
Muteins of human tear lipocalin
PIERIS AG41 citations92
US7252998B2Aug 7, 2007
Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
PIERIS AG50 citations92
US7892827B2Feb 22, 2011
Compound with affinity for the cytotoxic T lymphocyte-associated antigen (CTLA-4)
PIERIS AG21 citations89
US7723476B2May 25, 2010
Anticalins
PIERIS AG11 citations83
US7691970B2Apr 6, 2010
Muteins of a bilin-binding protein with affinity for a given target
PIERIS AG13 citations83
US7893208B2Feb 22, 2011
Muteins of human tear lipocalin
PIERIS AG5 citations73
PIERIS PHARMACEUTICALS GMBH
3 patentsUS10046027B2Aug 14, 2018
Muteins of tear lipocalin and methods for obtaining the same
PIERIS PHARMACEUTICALS GMBH8 citations82
US10618941B2Apr 14, 2020
Muteins of human lipocalin 2 (Lcn2,hNGAL) with affinity for a given target
PIERIS PHARMACEUTICALS GMBH6 citations81
US11827681B2Nov 28, 2023
Muteins of human lipocalin 2 (Lcn2, hNGAL) with affinity for a given target
PIERIS PHARMACEUTICALS GMBH0 citations59
EVONIK DEGUSSA GMBH
3 patentsUS10815508B2Oct 27, 2020
Enzymatic method for producing 2-hydroxy-4-methylmercaptobutanoic acid (MHA)
EVONIK DEGUSSA GMBH4 citations69
US9765370B2Sep 19, 2017
Method for aerobically producing alanine or a compound produced using alanine
EVONIK DEGUSSA GMBH4 citations68
US11034938B2Jun 15, 2021
Microorganism expressing mutant AlkB enzyme and use to prepare omega-hydroxy carboxylic acid and/or ester
EVONIK DEGUSSA GMBH0 citations58